Recent price moves and business snapshot Genscript Biotech (SEHK:1548) has seen the stock slip about 0.5% on the day and ...
PISCATAWAY, N.J., Aug. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (HK.1548), a global leader in life sciences innovation, today unveiled its new global brand platform: Scripting ...
The share-price surge came as promising cancer trial data overshadowed continuing scrutiny of China’s biotechnology sector by ...
In the rapidly evolving world of cancer treatments, CAR-T cell therapy stands out for its effectiveness tackling hematologic tumors. Booming demand for such therapies powered Legend Biotech Corp. LEGN ...
(Reuters) -The U.S. House of Representatives committee on China on Tuesday sent a letter to the directors of the FBI and national intelligence, renewing its concerns about GenScript Biotechnology's ...
Join us as we delve into the forefront of SARS-CoV-2 diagnostics and GenScript's transformative impact in the fight against COVID-19. We'll discuss the emergence of COVID-19 and GenScript's rapid ...
The two biotech leaders have embarked on a research project to streamline manufacturing The two biotech leaders have embarked on a research project to streamline manufacturing GenScript – the ...
GenScript ProBio is the subsidiary of GenScript Biotech Corp. (HK.1548), building upon GenScript’s solid gene synthesis technology and deep expertise in the antibody, cell, and gene therapy fields, ...
In the past decade, gene editing has been increasingly emphasized as an essential tool for therapy development. This has led to significant scientific advances in understanding disease mechanisms and ...
No-moat GenScript’s 01548 full-year results were in line with our expectations. Companywide revenue for the year was within 2% of our expectations. However, revenue growth from the non-cell therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results